PDS Biotechnology Launches Registered Direct Offering; Shares Up

MT Newswires Live
02-28

PDS Biotechnology (PDSB) said Thursday it is selling about 7.3 million common shares and warrants to purchase up to about 7.3 million common shares in a registered direct offering at a combined purchase price of $1.50 for institutional investors and $1.66 for certain PDS Biotechnology directors.

The company said about $11 million will be fully funded upon the closing of the offering, which is expected to occur on or about Friday, and up to $11 million more may be funded upon full cash exercise of the warrants, which have an exercise price of $1.50 per share, according to the company.

Net proceeds from the offering are expected to be used for research and development expenses and general corporate purposes, the company said.

Shares of PDS Biotechnology were up 4.6% in recent Thursday trading.

Price: 1.61, Change: +0.07, Percent Change: +4.55

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10